Open AccessAn Oat β-Glucan Beverage Reduces LDL Cholesterol and Cardiovascular Disease Risk in Men and Women with Borderline High Cholesterol: A Double-Blind, Randomized, Controlled Clinical Trial
Author(s) -
Thomas M.S. Wolever,
Maike Rahn,
Elhadji M. Dioum,
Susan E. Spruill,
Adish Ezatagha,
Janice Campbell,
Alexandra L. Jenkins,
YiFang Chu
Publication year - 2021
Publication title -
journal of nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.463
H-Index - 265
eISSN - 1541-6100
pISSN - 0022-3166
DOI - 10.1093/jn/nxab154
Subject(s) - cholesterol , medicine , ldl cholesterol , randomized controlled trial , double blind , cholesterol lowering , endocrinology , gastroenterology , pathology , placebo , alternative medicine
High-molecular-weight (MW) oat β-glucan (OBG), consumed at 3-4 g/d, in solid foods reduces LDL cholesterol by a median of ∼6.5%.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom